title: More than 54 months survival of a patient with lung adenocarcinoma after maintenance therapy with pemetrexed.
authors.forename: G
authors.initials: G
authors.lastname: Samelis
authors.forename: K
authors.initials: K
authors.lastname: Ekmektzoglou
authors.forename: S
authors.initials: S
authors.lastname: Giannakaki
authors.forename: A
authors.initials: A
authors.lastname: Tsiakou
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000401:mortality; D000077192:Adenocarcinoma of Lung; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D005971:Glutamates / Q000627:therapeutic use*; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000401:mortality; D000068437:Pemetrexed; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D005971:Glutamates; D000068437:Pemetrexed; D006147:Guanine